Tag Archives: PEIX

Hot Medical Stocks To Invest In 2021

IBM Retirement Fund decreased its holdings in shares of Eli Lilly And Co (NYSE:LLY) by 4.2% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 23,097 shares of the company’s stock after selling 1,006 shares during the period. IBM Retirement Fund’s holdings in Eli Lilly And Co were worth $1,787,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the business. BlackRock Inc. raised its position in shares of Eli Lilly And Co by 3.0% during the 1st quarter. BlackRock Inc. now owns 65,780,446 shares of the company’s stock valued at $5,089,436,000 after acquiring an additional 1,926,334 shares during the last quarter. Franklin Resources Inc. raised its position in shares of Eli Lilly And Co by 14.1% during the 1st quarter. Franklin Resources Inc. now owns 32,541,775 shares of the company’s stock valued at $2,517,762,000 after acquiring an additional 4,022,251 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Eli Lilly And Co by 4.3% during the 4th quarter. Geode Capital Management LLC now owns 9,854,964 shares of the company’s stock valued at $830,522,000 after acquiring an additional 406,812 shares during the last quarter. UBS Asset Management Americas Inc. raised its position in shares of Eli Lilly And Co by 1.8% during the 4th quarter. UBS Asset Management Americas Inc. now owns 6,636,386 shares of the company’s stock valued at $560,509,000 after acquiring an additional 115,499 shares during the last quarter. Finally, Alliancebernstein L.P. raised its position in shares of Eli Lilly And Co by 9.2% during the 4th quarter. Alliancebernstein L.P. now owns 4,351,659 shares of the company’s stock valued at $367,541,000 after acquiring an additional 365,011 shares during the last quarter. Institutional investors own 76.10% of the company’s stock.

Hot Medical Stocks To Invest In 2021: Vanguard Extended Duration Treasury ETF (EDV)

Vanguard Extended Duration Treasury ETF (the Fund) is an exchange-traded share class of Vanguard Extended Duration Treasury Index Fund. The Fund employs a passive management or indexing investment approach designed to track the performance of the Lehman Brothers Treasury STRIPS 20-30 Year Equal Par Bond Index (the Index). The Index measures the investment return of Treasury STRIPS, coupon and principal, with maturities ranging from 20 to 30 years. A Treasury STRIP represents a single coupon payment, or a single principal payment, from a United States Treasury security that has been stripped into separately tradable components. The Fund will invest at least 80% of its assets in the United States Treasury securities held in its target Index. The Fund may invest in derivatives. The Vanguard Group, Inc., through its Fixed Income Group, serves as the investment advisor of the Fund.
Advisors’ Opinion:

  • [By Peter Graham]

    Sandstorms due diligence is thorough, they dont just invest in any company. They like West Africa because they understand the area and the opportunities that exist there. Sandstorm is a royalty and streaming company, so they make these investments and receive cashflow deals that often kick in much later on. But they have already established a presence in Burkina and have deals in place with larger companies like Orezone Gold (TSXV: ORE) and Endeavour Mining (TSX: EDV). Sandstorms investment also potentially gives us access to their marketing department through something they call Launch Lab, and it looks like it will really benefit our own marketing efforts and will expose us to more opportunities over the coming year.

  • [By ]

    My preferred fund here is Vanguard Extended Duration Treasury ETF (NYSE: EDV), which owns a basket of long-term, zero-coupon bonds. It’s better-known, larger, and, most important, cheaper than its competitor PIMCO 25+ Year Zero Coupon U.S. Treasury Index Exchange-Traded Fund (NYSE: ZROZ). Both are poised to rally if deflation hits and the stock market falls. But EDV is cheaper, at only 0.07% expense ratio, compared with ZROZ’s 0.15%, and so it’s the one that makes the cut.

Hot Medical Stocks To Invest In 2021: Calamos Convertible and High Income Fund(CHY)

CALAMOS Convertible and High Income Fund (the Fund) is a diversified, closed-end management investment company. The Funds investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests at least 80% of its managed assets in a diversified portfolio of convertible and non-convertible income securities.

Calamos Advisors LLC (Calamos Advisors) is the Funds investment adviser. For the fiscal year ended October 31, 2007 (fiscal 2007), the Fund loaned one or more of its securities to broker-dealers and banks.

Advisors’ Opinion:

  • [By Shane Hupp]

    Calamos Convertible & Hi Income Fund (NASDAQ:CHY) declared a monthly dividend on Monday, February 4th, Wall Street Journal reports. Stockholders of record on Tuesday, February 12th will be given a dividend of 0.085 per share by the investment management company on Wednesday, February 20th. This represents a $1.02 annualized dividend and a dividend yield of 9.32%. The ex-dividend date of this dividend is Monday, February 11th.

  • [By Max Byerly]

    Calamos Convertible & Hi Income Fund (NASDAQ:CHY) was the target of a large growth in short interest in September. As of September 14th, there was short interest totalling 705,860 shares, a growth of 35.5% from the August 31st total of 521,121 shares. Approximately 1.0% of the company’s stock are short sold. Based on an average daily volume of 212,797 shares, the days-to-cover ratio is currently 3.3 days.

Hot Medical Stocks To Invest In 2021: Bovie Medical Corporation(BVX)

Bovie Medical Corporation, a medical device company, develops, manufactures, and markets electrosurgical devices and related medical products used in doctor’s offices, surgery centers, and hospitals worldwide. The company provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It also offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians from a group of specialties, including gynecology, general surgery, and urology. In addition, the company provides battery operated cauteries for precise hemostasis in ophthalmology; specialty lighting instruments for use in ophthalmology, as well as distributes specialty lighting instruments for general surgery, hip replacement surgery, and endotracheal tubes placement; penlights used in physician offices; and a nerve locator stimulator primarily used for identifying motor nerves in hand and facial reconstructive surgery. Further, it develops J-Plasma, a patented helium-based plasma surgical product, as well as designs, develops, and manufactures electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing agreements. Bovie Medical Corporation markets its products through own brands, such as Bovie, IDS, and ICON, as well as on a private label basis to distributors. The company was formerly known as An-Con Genetics Inc. and changed its name to Bovie Medical Corporation in October 1998. Bovie Medical Corporation was incorporated in 1982 and is headquartered in Clearwater, Florida.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Bovie Medical Corp (NYSEMKT:BVX)Q42018 Earnings Conference CallMarch 13, 2019, 4:30 p.m. ET

    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:


  • [By Ethan Ryder]

    TheStreet upgraded shares of Bovie Medical (NYSEAMERICAN:BVX) from a d rating to a c- rating in a research report report published on Monday morning.

  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close

Hot Medical Stocks To Invest In 2021: J.M. Smucker Company (SJM)

The J. M. Smucker Company manufactures and markets branded food products worldwide. It operates through four segments: U.S. Retail Coffee; U.S. Retail Consumer Foods; U.S. Retail Pet Foods; and International, Foodservice, and Natural Foods. The company provides various consumer food and beverage products, including coffee, peanut butter, fruit spreads, shortening and oils, baking mixes and ready-to-spread frostings, canned milk, flour and baking ingredients, juices and beverages, frozen sandwiches, toppings, syrups, pickles, condiments, grain products, and nut mix products; and pet products comprising dry and wet dog food, dry and wet cat food, dog snacks, and cat snacks. It markets its products under the Folgers, Dunkin Donuts, Smuckers, Jif, Crisco, Pillsbury, Uncrustables, Douwe Egberts, Folgers Gourmet Selections, Millstone, Cafe Bustelo, Cafe Pilon, K-Cup, Adams, Laura Scudders, Hungry Jack, Eagle Brand, Magnolia, Robin Hood, Five Roses, Santa Cruz Organic, R. W. Knudsen Family, truRoots, Meow Mix, Milk-Bone, Kibbles n Bits, Natural Balance, 9Lives, Pup-Peroni, Gravy Train, and Natures Recipe brand names. The company sells its products through direct sales and brokers to food retailers, food wholesalers, drug stores, club stores, mass merchandisers, discount and dollar stores, military commissaries, and pet specialty stores; and through retail channels, foodservice distributors and operators, and natural foods stores and distributors. The J. M. Smucker Company was founded in 1897 and is headquartered in Orrville, Ohio.

Advisors’ Opinion:

  • [By Ethan Ryder]

    J M Smucker (NYSE:SJM) and Farmmi (NASDAQ:FAMI) are both consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, dividends and valuation.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage gain in the S&P 500 ahead of the close was The J. M. Smucker Co. (NYSE: SJM) which rose by about 5% to $106.11. The stocks 52-week range is $91.32 to $133.38. Volume was about 2.6 million compared to the daily average volume of 1.2 million.

Hot Medical Stocks To Invest In 2021: Pacific Ethanol Inc.(PEIX)

Pacific Ethanol, Inc. produces and markets low carbon renewable fuels in the United States. It sells ethanol to gasoline refining and distribution companies; provides ethanol transportation, storage, and delivery services in the Western United States, primarily in California, Arizona, Nevada, Utah, Oregon, Colorado, Idaho, and Washington; and markets ethanol co-products, including wet distiller grains and syrup to dairy operators and animal feed distributors. The company also provides operations, maintenance, and accounting services to a cellulosic integrated bio-refinery in Boardman, Oregon. Pacific Ethanol, Inc. was founded in 2003 and is headquartered in Sacramento, California.

Advisors’ Opinion:

  • [By Paul Ausick]

    Pacific Ethanol Inc. (NASDAQ: PEIX) saw short interest tumble by 33.8% in the two-week period to 390,895 shares, about 0.9% of the company’s float. Days to cover remained unchanged at two. The stock price dropped by about 8.9% between the settlement dates. Shares closed at $1.15 on Wednesday, down about 0.9% for the day, in a 52-week range of $0.76 to $4.15.

  • [By Shane Hupp]

    Pacific Ethanol Inc (NASDAQ:PEIX) dropped 5.1% on Thursday . The company traded as low as $2.32 and last traded at $2.48. Approximately 53,022 shares traded hands during mid-day trading, a decline of 91% from the average daily volume of 606,388 shares. The stock had previously closed at $2.36.

  • [By Paul Ausick]

    Pacific Ethanol Inc. (NASDAQ: PEIX) saw short interest fall by 0.7% in the two-week period to 859,540 shares, which is about 2% of the company’s float. Days to cover rose from two to three. The stock price tumbled by about 14.9% in the first two weeks of September. Shares closed at $1.95 on Tuesday, down 2.5% for the day, in a 52-week range of $1.55 to $6.06.